ACM  >> Vol. 7 No. 4 (October 2017)

    泰山玉竹多糖对小鼠糖尿病的治疗作用及细胞免疫机制研究
    Effect and Cellular Immunological Mechanism on Mice of Diabetes with Extraction of Polysaccharide from Taishan Polygonatum odoratum

  • 全文下载: PDF(404KB)    PP.258-263   DOI: 10.12677/ACM.2017.74043  
  • 下载量: 802  浏览量: 2,485   科研立项经费支持

作者:  

郭珊珊,张 雪,刘宁宁,修鹏程:泰山医学院,山东 泰安

关键词:
泰山玉竹多糖1型糖尿病细胞免疫Extraction Form Taishan Polygonatum odoratum (EA-PAOA) Type 1 Diabetes Cellular Immunity

摘要:

目的:研究泰山玉竹提取物玉竹多糖(EA-PAOA)对I型糖尿病小鼠的降血糖作用及可能的细胞免疫学机制。方法:采用常规的链脲佐菌素(STZ)多次注射诱导法制备I型糖尿病小鼠模型,试验组分低、中、高三个剂量灌胃等体积的EA-PAOA,对照组灌胃等体积的生理盐水。于用药后1~4周每周检测各组小鼠血糖和胰岛素水平;通过流式细胞仪检测外周血CD4+T细胞和CD8+T细胞比例,采用酶联免疫吸附实验(ELISA)检测血清Th1型细胞因子γ干扰素(IFN-γ)和Th2型细胞因子白细胞介素4 (IL-4)浓度。最后进行数据的统计学分析。结果:与模型组相比,实验组空腹血糖水平显著降低(P < 0.05~0.01);胰岛素水平则显著升高(P < 0.01);外周血CD4+T细胞比例显著降低而CD8+T细胞比例显著降低(P < 0.01),CD4+/CD8+比例显著降低(P < 0.01)。血清中Th1型细胞因子IFN-γ显著降低(P < 0.05~0.01),而Th2型细胞因子IL-4显著升高(P < 0.05~0.01)。结论:泰山玉竹多糖治疗能明显降低1型糖尿病小鼠血糖,其降糖作用可能通过调节糖尿病小鼠T细胞亚群及Th1型和Th2型细胞因子水平而发挥的。

Objective: To study the therapeutic effects of extraction from Polygonatum odoratum (EA-PAOA) from Taishan on type 1 diabetes and the possible immunological mechanism. Methods: Diabetic mouse models were established by repeated injection of small dosage of STZ. Mice were divided into 3 different groups according to different concentrations of EA-PAOA which were administrated by intragastric. The control group was administrated the same volume saline by intragastric. Changes of blood glucose, insulin were monitored from 1 to 4 weeks after administration. Changes of levels of serum interferon γ (IFN-γ) and interleukin-4(IL-4) in diabetic mouse were tested with enzyme- linked immunosorbent assay (ELISA) after administration. Finally, data were analyzed by statistic method. Results: Levels of blood glucose were significantly lower after administration in all extrac-tion groups than that in the model group (P < 0.05 - 0.01). Levels of insulin were significantly higher after administration in all extraction groups than that in the model group (P < 0.01). In the periph-eral blood, CD4+ T cells were significantly decreased, whereas CD8+ T cells were significantly in-creased (P < 0.01), and the ratio of CD4+/CD8+ was significantly decreased (P < 0.05 - 0.01). Levels of type 1 cytokine IFN-γ were lower in each extraction groups than that in the model group, whereas levels of type 2 cytokine IL-4 were significantly higher in each extraction groups than that in the model group (P < 0.05 - 0.01). Conclusion: EA-PAOA can markedly decrease the blood glucose of the in mice with diabetes. The mechanisms were probably related to regulating of T cell subsets.

文章引用:
郭珊珊, 张雪, 刘宁宁, 修鹏程. 泰山玉竹多糖对小鼠糖尿病的治疗作用及细胞免疫机制研究[J]. 临床医学进展, 2017, 7(4): 258-263. https://doi.org/10.12677/ACM.2017.74043

参考文献

[1] 张立新, 庞维, 付京晶, 等. 玉竹对STZ诱导的1型糖尿病小鼠的降糖作用中药药理与临床[J]. 2012, 28(2): 106-108.
[2] 刘燊, 胡彦君. 玉竹提取物玉竹多糖对 1型糖尿病小鼠的作用研究[J]. 广州医药, 2009, 40(6): 49-52.
[3] Al-Awar, A., Kupai, K., Veszelka, M., et al. (2016) Experimental Diabetes Mellitus in Different Animal Models. Journal of Diabetes Research, 2016, Article ID: 9051426.
https://doi.org/10.1155/2016/9051426
[4] Sun, W., Wang, L.Y., Zhang, Z.M., et al. (2003) Intramuscular Transfer of Naked Calcitonin Gene-Related Peptide Gene Prevents Autoimmune Diabetes Induced by Multiple Low-Dose Streptozotocin in C57BL Mice. European Journal of Immunology, 33, 233-242.
https://doi.org/10.1002/immu.200390026
[5] Kulshrestha, D., Yeh, L.T., Chien, M.W., et al. (2017) Peripheral Autoimmune Regulator Induces Exhaustion of CD4+ and CD8+ Effector T Cells to Attenuate Autoimmune Diabetes in Non-Obese Diabetic Mice. Frontiers in Immunology, 8, 1128.
https://doi.org/10.3389/fimmu.2017.01128
[6] Walker, L.S. and von Herrath, M. (2016) CD4 T Cell Differenti-ation in Type 1 Diabetes. Clinical & Experimental Immunology, 183, 16-29.
https://doi.org/10.1111/cei.12672
[7] Kumar, N.P., Moideen, K., George, P.J., et al. (2016) Coincident Diabetes Mellitus Modulates Th1-, Th2-, and Th17-Cell Responses in Latent Tuberculosis in an IL-10- and TGF-Beta-Dependent Manner. European Journal of Immunology, 46, 390-399.
https://doi.org/10.1002/eji.201545973
[8] Nekoua, M.P., Fachinan, R., Atchamou, A.K., Nouatin, O., Amoussou-Guenou, D., Amoussou-Guenou, M.K., Moutairou, K. and Yessoufou, A. (2016) Modulation of Immune Cells and Th1/Th2 Cytokines in Insulin-Treated Type 2 Diabetes Mellitus. African Health Sciences, 16, 712-724.
https://doi.org/10.4314/ahs.v16i3.11
[9] Vaseghi, H. and Jadali, Z. (2016) Th1/Th2 Cytokines in Type 1 Diabetes: Relation to Duration of Disease and Gender. Indian Journal of Endocrinology and Metabolism, 20, 312-316.
https://doi.org/10.4103/2230-8210.180002